Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D001499:Bayes Theorem; D004347:Drug Interactions; D015233:Models, Statistical; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D014700:Verapamil / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D014700:Verapamil